Human HSD3B1+ HSD3B2 Ready-To-Use IHC Kit Size:50 Test 3ml RTU -20°C 9 Counter

3ml RTU -20°C 9 Counter Staining Reagent 5ml RTU RT 10 Differentiation Reagent 6ml RTU RT 11 Mounting Media 5ml RTU RT 12 Control slide (human colon cancer) 1 slide RTU RT 13 Datasheet 1 copy

Conjugation None Clone# Cetuximab Formulation 100 mM Pro-Ac 20mM Arg pH 5

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Human Integrin alpha 2 Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (Goat Anti-Rabbit IgG H&L / HRP) 6ml RTU 2-8°C 7 Chromogen Component A 0

Bioss Antibodies) were stained for Peripherin according to the manufacturer's instructions

Histone H3/j

Human HSD3B1+ HSD3B2 Ready-To-Use IHC Kit Size:50 Test 3ml RTU -20°C 9 CounterHuman HSD3B1+ HSD3B2 Ready To Use IHC Kit Cat. No.: IHC0187H Sample Type: FFPE tissue Size: 50T (including a control slide) Storage and Stability: Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. Background Amyloid beta peptide (Abeta Beta amyloid) is the major constituent of amyloid plaques in the brains of individuals afflicted with Alzheimer's disease.